Generating clinical evidence for treatment and prevention options for long COVID.

导出原文传递

翻译打印收藏纠错

第一作者： Stephanie,Buchholz

第一单位： European Medicines Agency, Amsterdam, The Netherlands.;Federal Institute for Drugs and Medical Devices, Bonn, Germany.

作者： Stephanie,Buchholz ^[1] ; Eugenia,Di Meco ^[2] ; Ewa Z,Bałkowiec-Iskra ^[3] ; Bruno,Sepodes ^[4] ; Marco,Cavaleri ^[5]

作者单位： European Medicines Agency, Amsterdam, The Netherlands.;Federal Institute for Drugs and Medical Devices, Bonn, Germany. ^[1] European Medicines Agency, Amsterdam, The Netherlands.;EMA Emergency Task Force, Amsterdam, The Netherlands. ^[2] EMA Emergency Task Force, Amsterdam, The Netherlands.;Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, Poland.;The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, Warsaw, Poland.;EMA Committee for Medicinal Products for Human Use, Amsterdam, The Netherlands. ^[3] EMA Emergency Task Force, Amsterdam, The Netherlands.;EMA Committee for Medicinal Products for Human Use, Amsterdam, The Netherlands.;Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal. ^[4] European Medicines Agency, Amsterdam, The Netherlands. Marco.Cavaleri@ema.europa.eu.;EMA Emergency Task Force, Amsterdam, The Netherlands. Marco.Cavaleri@ema.europa.eu. ^[5]

主题词人类(Humans);抗病毒药(Antiviral Agents)

DOI 10.1038/s41591-024-03031-5

PMID 38806678

发布时间 2024-09-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Nature medicine

2024年30卷8期

2109-2110页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Generating clinical evidence for treatment and prevention options for long COVID.

Nature medicine

相似文献

Nature medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Generating clinical evidence for treatment and prevention options for long COVID.

Nature medicine

相似文献

Nature medicine

相关期刊

检索历史清除